We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
GLSI icon
576
Greenwich LifeSciences
GLSI
$256M
$256M $17.41 8.37%
LCTX icon
577
Lineage Cell Therapeutics
LCTX
$253M
$253M $1 2.91%
SPOK icon
578
Spok Holdings
SPOK
$251M
$251M $11.99 1.78%
FATE icon
579
Fate Therapeutics
FATE
$249M
$249M $2.08 4.15%
ABEO icon
580
Abeona Therapeutics
ABEO
$249M
$249M $4.35 4.61%
CAMP icon
581
CAMP4 Therapeutics
CAMP
$249M
$249M $3.96 1.54%
ALEC icon
582
Alector
ALEC
$247M
$247M $2.21 1.34%
BDSX icon
583
Biodesix
BDSX
$245M
$245M $23.25 5.95%
IFRX icon
584
InflaRx
IFRX
$245M
$245M $1.66 3.49%
EVMN icon
585
Evommune Inc
EVMN
$244M
$244M $6.73 1.17%
IMRX icon
586
Immuneering
IMRX
$243M
$243M $3.75 6.72%
LFCR icon
587
Lifecore Biomedical
LFCR
$243M
$243M $6.40 1.84%
LAB icon
588
Standard BioTools
LAB
$241M
$241M $0.6100 1.61%
PROF icon
589
Profound Medical
PROF
$240M
$240M $6.57 12.1%
OCGN icon
590
Ocugen
OCGN
$238M
$238M $0.7027 5.58%
HITI icon
591
High Tide
HITI
$230M
$230M $2.58 3.01%
VNDA icon
592
Vanda Pharmaceuticals
VNDA
$229M
$229M $3.79 6.42%
TLSI icon
593
TriSalus Life Sciences
TLSI
$228M
$228M $3.70 4.15%
ELDN icon
594
Eledon Pharmaceuticals
ELDN
$225M
$225M $2.77 8.88%
XHS icon
595
State Street SPDR S&P Health Care Services ETF
XHS
$225M
$225M $143.17 0.82%
ELMD icon
596
Electromed
ELMD
$224M
$224M $27.04 2.31%
SLGL icon
597
Sol-Gel Technologies
SLGL
$224M
$224M $68.35 0.45%
ACIU icon
598
AC Immune
ACIU
$221M
$221M $2.22 6.33%
KROS icon
599
Keros Therapeutics
KROS
$219M
$219M $11.04 2.82%
SIGA icon
600
SIGA Technologies
SIGA
$218M
$218M $3.04 4.4%
22 23
24
25 26

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,121 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $10T.

The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $658B and AbbVie (ABBV) at $521B.

Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.

  • Combined market cap: $10T across 1,121 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.26T market cap.
  • Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.